LP135443-2
Rilpivirine
Active
Description
Rilpivirine (brand name Edurant) is a pharmaceutical drug, developed by Tibotec, for the treatment of HIV infection. It is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs, such as efavirenz. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, http://en.wikipedia.org/wiki/Rilpivirine
Basic Part Properties
- Part Display Name
- Rilpivirine
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2011-09-21
- Construct for LOINC Short Name
- Rilpivirine
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP135443-2 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP135443-2
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 利匹韦林 Synonyms: 4-[4-[4-[(E)-2-Cyanovinyl]-2,6-dimethylphenylamino]pyrimidin-2-ylamino]benzonitrile; |
| es-ES | Spanish (Spain) | Rilpivirina |
| it-IT | Italian (Italy) | Rilpivirina |
| tr-TR | Turkish (Turkey) | Rilpivirin |
| ru-RU | Russian (Russian Federation) | Рилпивирин |
| nl-NL | Dutch (Netherlands) | rilpivirine |
| fr-CA | French (Canada) | Rilpivirine |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright